PERMS in Oslo and Vestre Viken

Article

|

Last update

This information is for women who are eligible for participation in the PERMS study in BreastScreen Norway in Oslo and Vestre Viken. Read about why you have been invited and what participation means.

Who is eligible for participation in PERMS?

You are eligible for participation in PERMS in Oslo and Vestre Viken if you undergo follow-up assessment during the study period and are not diagnosed with breast cancer. You will receive information and an invitation to the study in the following ways:

  1. In the appointment letter for the follow-up assessment. Here, you receive the first information about the PERMS study and your right to opt out from receiving an invitation. We strongly encourage you to attend the follow-up assessment if you have been summoned, regardless of whether you wish to participate in the study or not.
  2. In the invitation letter for a new mammogram, one year after your original screening examination. You only receive this letter if you were not diagnosed with breast cancer at the follow-up assessment and you did not opt out of being invited to the study. 

The study period in Vestre Viken began in December 2025. 

The study period in Oslo started in April 2026.

Why are you invited to PERMS?

Women in Oslo and Vestre Viken who have experienced a "false alarm" after their screening examination are invited to an extra screening examination with mammography after one year.

A "false alarm" means undergoing additional examinations without being diagnosed with breast cancer. In medical terms, this is called a false positive screening result. Studies have shown that those who have had such a false alarm have a slightly higher risk of being diagnosed with breast cancer later compared to women who have not been called in for additional examinations.

For women who have had a "false alarm", it may therefore be beneficial to have a new mammogram after one year. This extra examination can help detect breast cancer earlier, which increases the possibility of effective treatment.

What does participation mean for you?

If you choose to participate in the PERMS study and attend the extra screening examination after one year, you will be asked to provide written consent at your appointment.

  • The extra mammography examination is conducted in the same way as regular screening
  • You can go home after the mammogram
  • You will receive results within two to four weeks, just as you would after regular screening
  • The examination has a copayment of 387 NOK, and you cover your own travel expenses

If additional examinations and further follow-up are needed, these will occur according to standard procedures.

Brief overview of PERMS

Purpose

In the study, we offer extra examinations to specific groups of women in order to find out

  • how many will use such an offer
  • the outcomes of the extra examination  

Knowledge from this study will be used to further develop the screening programme for women in BreastScreen Norway.

Benefits and harms

  • Having a new mammogram after one year can improve the chances of early detection of breast cancer. In general, early detection of breast cancer can lead to more gentle treatment, better quality of life, and fewer deaths from the disease than if discovered due to symptoms.
  • An extra mammogram can result in another "false alarm", which can cause worry and anxiety. It is also known that breast cancer can be missed on mammograms.
  • Breast cancer may be detected that would not have caused symptoms and would not have been found without screening participation, known as overdiagnosis. Today, it is not possible to distinguish such tumors from those that would cause symptoms. Therefore, all women diagnosed with breast cancer are offered treatment.
  • Mammography is an X-ray examination of the breast. Some find mammography uncomfortable or painful when the breast is compressed for a few seconds during imaging. Please let the radiographers know if you experience discomfort.
  • Mammography uses ionizing radiation, and annual examinations give a higher radiation dose compared to mammography every two years. However, the dose is very low, and the risk of developing breast cancer from screening is minimal. 

Privacy and your rights

Participation in the study is voluntary. You can opt out of having information from your follow-up assessment being used to invite you to an extra screening examination. Even if you do not opt out, it is voluntary to attend the extra examination. Regardless of your participation in the study, you will receive a new invitation to BreastScreen Norway in two years if you are still in the target group.

Not participating, or if you later wish to withdraw from the study, will have no consequences for future invitations or participation in BreastScreen Norway. You will not be charged for the examination if you do not attend. You have the right to access the information stored about you in the study, and demand corrections or deletions in accordance with the provisions of the Health Research Act and the General Data Protection Regulation. 

If you choose to participate in the study, you will be asked to give your written consent when you attend the extra examination. 

We process your personal data based on public interest (General Data Protection Regulation 6.1.e and 9.2.j). 

The Regional Ethics Committee (REK) has approved the study (REK #585149). 

Contact information

The Cancer Registry at NIPH is project leader and the coordinating institution. If you have questions regarding the study, you can contact senior adviser at the Cancer Registry, NIPH, Gunvor Gipling Wåde.

If you have questions about privacy in the study, you can contact the data protection officer for the Cancer Registry, NIPH: personvernombud@fhi.no, the data protection officer at Vestre Viken: personvern@vestreviken.no, or the data protection officer at Oslo University Hospital: personvern@ous-hf.no. 

You may also complain to the Data Protection Authority if you believe there is a breach of the data protection regulations: Complaint to the Data Protection Authority (datatilsynet.no).

Published | Last update